Famotidine and omeprazole
Pro Research Analysisby 
Searched over 200M research papers
Comparative Efficacy of Famotidine and Omeprazole in Dogs and Humans
Introduction to Famotidine and Omeprazole
Famotidine and omeprazole are commonly used medications for the treatment of acid-related disorders. Famotidine is an H2-receptor antagonist, while omeprazole is a proton pump inhibitor (PPI). Both drugs are used to reduce gastric acid secretion, but they function through different mechanisms and have varying degrees of efficacy depending on the condition being treated.
Efficacy in Dogs: Intragastric pH Control
Famotidine vs. Omeprazole in Dogs
A study comparing the effects of oral famotidine and two formulations of omeprazole (tablet and reformulated paste) on intragastric pH in dogs found that both omeprazole formulations significantly increased intragastric pH compared to famotidine and placebo. Specifically, the mean percentage of time that intragastric pH was ≥3 and ≥4 was significantly higher for omeprazole tablets and paste compared to famotidine, indicating superior acid suppression by omeprazole .
Prevention of Exercise-Induced Gastritis
In racing Alaskan sled dogs, omeprazole was found to be more effective than high-dose famotidine in reducing the severity and prevalence of exercise-induced gastric lesions. While famotidine did provide some benefit compared to no treatment, omeprazole significantly decreased the severity and prevalence of gastric lesions, making it the preferred choice for preventing stress-associated gastric disease in these dogs .
Efficacy in Humans: Gastric Acid Suppression and Ulcer Healing
Intravenous Administration in Healthy Subjects
A study comparing single intravenous doses of omeprazole and famotidine in healthy male subjects found that famotidine increased intragastric pH more rapidly than omeprazole. Famotidine maintained a higher pH for a longer duration during the study period, suggesting it may be more effective for rapid acid suppression in acute settings .
Reflux Esophagitis and Duodenal Ulcers
In the treatment of reflux esophagitis, both omeprazole and famotidine are used, but there is no consensus on which should be the first-choice drug. However, in the healing of duodenal ulcers, omeprazole was found to be superior to famotidine. Omeprazole provided faster ulcer healing and more rapid pain relief compared to famotidine, although both drugs had similar relapse rates after treatment cessation Kawano2002Misra1993.
Prevention of Delayed Bleeding Post-ESD
In a study comparing the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection (ESD), it was found that both drugs were effective, but the study did not conclusively determine which was superior. This suggests that either drug could be used based on clinical judgment and patient-specific factors .
Impact on Gastrointestinal Adverse Events in Dogs with Cancer
In dogs with cancer treated with piroxicam, neither omeprazole nor famotidine reduced the frequency or severity of gastrointestinal adverse events (AEs) compared to placebo. In fact, omeprazole was associated with more frequent and severe GI AEs, indicating that these medications should not be used prophylactically with NSAIDs in dogs with cancer .
Influence on Antiplatelet Effects in ACS Patients
In patients with acute coronary syndromes (ACS) receiving clopidogrel, a study found no significant difference in platelet reactivity between those treated with omeprazole and those treated with famotidine. This suggests that low-dose omeprazole does not significantly attenuate the antiplatelet effects of clopidogrel, making it a viable option for acid suppression in these patients .
Conclusion
Both famotidine and omeprazole are effective in reducing gastric acid secretion, but their efficacy varies depending on the specific condition and patient population. Omeprazole generally provides superior acid suppression and faster ulcer healing compared to famotidine, making it the preferred choice for many acid-related disorders. However, famotidine may offer more rapid pH control in acute settings. Clinicians should consider the specific needs of their patients and the clinical context when choosing between these medications.
Sources and full results
Most relevant research papers on this topic